AstraZeneca PLC Equity-NMS: AZN

Healthcare

Drug Manufacturers-General

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$74.25

52W high :

$76.56

1Y :

19.85%

5Y :

103.61%

EPS(TTM): :

1.51

Shares O/S :

3.1 B

Market cap :

229.56 B

What is the share price of AstraZeneca PLC today?

AstraZeneca PLC (AZN) share price as of June 9, 2023, is $74.06. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of AstraZeneca PLC?

Yes, Indian Investors can invest in the AstraZeneca PLC (AZN) Share by opening an international trading account with Angel One.

How can I purchase AstraZeneca PLC shares in India?

Purchasing AstraZeneca PLC (AZN) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying AstraZeneca PLC (AZN) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of AstraZeneca PLC?

Yes, you can purchase fractional shares of AstraZeneca PLC (AZN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of AstraZeneca PLC?

The market capitalization of AstraZeneca PLC on June 9, 2023, is $229.56 B.

In which sector AstraZeneca PLC belongs?

AstraZeneca PLC operates in the Healthcare sector, specifically in the Drug Manufacturers-General industry.

What documents are required to invest in AstraZeneca PLC stocks?

In order to invest in AstraZeneca PLC (AZN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

AstraZeneca PLC is a science-led biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 179 projects. Its key marketed oncology products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Zoladex, Faslodex and others. Its rare diseases products include Soliris, Ultomiris, Strensiq and Kanuma. Its BioPharmaceuticals products include Farxiga, Lokelma, Crestor, Breztri and others. Its geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia. It is also focused on discovering, developing, and manufacturing of T-cell receptor therapies.